Navigation Links
Dyadic Netherlands Enters Into R&D Collaboration With Sanofi Pasteur and EnGen Bio
Date:5/2/2011

JUPITER, Fla. and WAGENINGEN, Netherlands, May 2, 2011 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the biopharmaceutical, biofuels and industrial enzyme industries, announced today that its research and development subsidiary, Dyadic Nederland B.V. ("Dyadic Netherlands"), has entered into a research agreement with Sanofi Pasteur, the vaccines division of sanofi-aventis Group, and EnGen Bio, Inc.

(Logo: http://photos.prnewswire.com/prnh/20091214/DYADICLOGO)

Under the agreement, Sanofi Pasteur will fund collaborative research at Dyadic Netherland's research and development facility in Wageningen, The Netherlands, which will utilize Dyadic's proprietary and patented C1 Platform Technology for certain vaccine applications. The research will be conducted under the guidance and direction of Dyadic Netherland's General Manager, Dr. ir. Wim van der Wilden, with coordination by Dr. Mark Alfenito, the President and CEO of EnGen Bio. The research is anticipated to be completed in six to twelve months. All other terms of the research collaboration are confidential.

Sanofi Pasteur, based in Lyon, France, is the largest company entirely dedicated to vaccines. For more information, please visit: www.sanofipasteur.com or www.sanofipasteur.us

EnGen Bio, based in Redwood City, California, is an early stage biopharmaceutical company that is working to develop biopharmaceutical applications for Dyadic's proprietary and patented C1 Platform Technology. For more information, please visit: www.engenbio.com.

Dyadic's President and Chief Executive Officer, Mark Emalfarb, stated, "We are very pleased to have the opportunity to work with Sanofi Pasteur and EnGen Bio to further dem
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New U.S. Patent Issued to Dyadic International
2. Dyadic International to Present at Advanced Biofuels Leadership Conference
3. Dyadic International Introduces Advanced Biofuels Enzyme AlternaFuel® CMAX™ At World Biofuels Markets
4. Dyadic International Reports 2010 Fiscal Year Financial Results
5. Dyadic International Launches High Performance Enzyme for Pulp and Paper Industry Using New C1 Production Platform
6. Dyadic International Reports 2010 Third Quarter Financial Results
7. Dyadic International to Announce Third Quarter 2010 Financial Results and Hold Conference Call on November 15, 2010
8. Dyadic International Raises $3 Million in Private Placement of Convertible Notes
9. Dyadic International to Announce Second Quarter 2010 Financial Results and Hold Conference Call on August 13, 2010
10. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
11. Dyadic International Engages The Abraham Group as Strategic Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 4, 2015  Blueprint Medicines (NASDAQ: BPMC ... kinase drugs for genomically defined diseases, today announced that ... a company overview at the 2015 Wedbush PacGrow Healthcare ... EDT. A live webcast of the event ... the Blueprint Medicines website at www.blueprintmedicines.com . An ...
(Date:8/4/2015)... Francisco, CA (PRWEB) , ... August 04, 2015 , ... ... difference by inviting a diverse selection of entrepreneurs from across the United States to ... CEO Jessica Richman is honored to be chosen to be among the attendees. , ...
(Date:8/4/2015)... , Aug. 4, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: ... in China , today announced that ... second quarter, ended June 30, 2015, after market close ... conference call on Thursday, August 13, 2015, at 8:00 ... China Standard Time) to review the Company,s financial results ...
(Date:8/3/2015)... GREENVILLE, N.C. , Aug. 3, 2015 /PRNewswire/ ... will unveil its new Fingerprint Molecular Identification™ (FMID) ... Identification,s educational conference in Sacramento, Calif. ... in forensic science, will enable law enforcement agents, ... molecular profile of criminal suspects. By ...
Breaking Biology Technology:White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results 2ArroGen Previews New Fingerprint Molecular Identification Technology 2
... NEW YORK, April 28, 2011 Keryx Biopharmaceuticals (Nasdaq: ... from the Phase 3 short-term clinical trial of Zerenex ... in end-stage renal disease patients on dialysis.  The Zerenex ... Foundation Spring Clinical Meetings being held in Las Vegas, ...
... Mich., April 28, 2011 Vestaron Corporation, a Kalamazoo-based ... products, announced today that John Sorenson, Ph.D., will serve ... of Directors thanks John McIntyre for his years of ... agriculture. "John,s scientific leadership has been just ...
... Genomatica , an emerging leader in ... chemical maker in the world, signed a broad memorandum of ... , Study of a j oint venture ... Asia :  Mitsubishi and Genomatica will explore forming a joint ...
Cached Biology Technology:Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study 2Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study 3Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study 4Vestaron Corporation Announces New Leadership 2Vestaron Corporation Announces New Leadership 3Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia 2Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia 3
(Date:7/31/2015)... SHENZHEN, China , 31 de julio de 2015 /PRNewswire/ ... www.icg-10.org ) se celebrará por medio de BGI del 22 ... China . Este año, la conferencia ... 2006, ICG se ha convertido en una de las reuniones ... de ser una de las reuniones más dinámicas, entusiastas y ...
(Date:7/31/2015)... , July 31, 2015 The 10 th ... be held by BGI from October 22-25, 2015, in ... The conference is celebrating its 10 th anniversary this ... of the world,s most influential annual meetings in the ,omics, ... enjoyable scientific gatherings. ICG-10 focuses on recent ...
(Date:7/27/2015)... , July 27, 2015   Zynx ... and experience-based clinical improvement solutions, today announced that ... is now available on Android smartphones and tablets. ... and post-care organizations can use ZynxCarebook to securely ... patient,s condition, streamline care transitions to other care ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3
... near stagnation, four new drugs could help make advanced prostate ... leading Colorado prostate cancer expert says. "It,s not just ... One is a bone protective agent; another,s a more effective ... the first drug tested for cancer immunotherapy," says E. David ...
... New York (February 16, 2012)The Republic of Congo ... increasingly rare treasure: one of Africa,s most pristine forests ... exposure to humans that the curious apes investigate the ... Known as the Goualougo Triangle, the 100-plus square-mile dense ...
... have found a way to generate and maintain stem cells ... protein., Researchers from Denmark, Scotland and the USA have created ... such as skin cells so that they can subsequently ... cells have the potential to become any cell in the ...
Cached Biology News:4 new drugs will change prostate cancer care 2Great news for chimpanzees 2Great news for chimpanzees 3Synthetic protein amplifies genes needed for stem cells 2Synthetic protein amplifies genes needed for stem cells 3
... to rapidly and reliably amplify unknown ... APA Technology. APAgene provides hassle-free, ready-to ... price. All necessary ingredients are provided ... can be used for identifying transgene/genomic ...
Recommended for supporting the growth of anchorage-dependent cells including human and mouse stromal cells, mesenchymal cells and cell lines....
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: cap, ...
Extremely high efficiency packaging extracts useful for transfecting our EpiFOS™ or CopyControl™ Fosmids, or any DNA vector with cos sites. A tremendous value when conpared to the competition...
Biology Products: